vTv Therapeutics Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for vTv Therapeutics Inc. (VTVT) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018
Operating Activities
Net Income-18.46-20.25-19.16-12.99-8.50-21.94-23.85
Depreciation & Amortization0.090.090.090.090.090.570.22
Stock Based Compensation2.761.581.272.361.010.000.00
Change in Working Capital-5.444.395.390.04-2.71-1.65-7.55
Change in Accounts Receivable0.040.07-0.120.10-0.150.000.00
Change in Accounts Payable-5.222.93-0.861.83-1.000.000.00
Change in Other Working Capital-0.251.39-0.40-0.89-1.530.000.00
Other Operating Activities-4.25-6.08-7.19-6.35-4.030.281.01
Net Cash from Operating Activities-25.31-19.08-16.02-19.31-18.00-23.02-26.86
Investing Activities
Capital Expenditures0.000.00-0.020.000.000.070.00
Purchases of Investments0.004.400.000.000.000.000.00
Sales/Maturities of Investments0.004.400.000.000.000.000.00
Other Investing Activities0.000.000.000.000.000.000.01
Net Cash from Investing Activities0.004.40-0.020.000.000.240.01
Financing Activities
Debt Repayment-0.19-0.60-0.81-0.72-5.46-10.57-5.39
Common Stock Issued52.8012.0314.7926.8024.435.4421.50
Other Financing Activities0.000.005.040.0010.0027.500.00
Net Cash from Financing Activities52.6112.0014.7526.9819.4722.8716.61
Summary
Net Change in Cash27.30-2.68-1.297.671.470.09-10.24
Cash at Beginning of Period9.4512.1313.425.754.284.1814.42
Cash at End of Period36.759.4512.1313.425.754.284.18
Free Cash Flow-25.31-19.08-16.04-19.31-18.00-22.78-26.86
Supplemental Disclosures
Interest Paid0.000.010.020.010.621.302.28
Income Taxes Paid0.100.000.200.120.000.101.00